4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:血管内皮生长因子-C, Spp1, IRF-3, DPYSL2, GLUT5
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Sandwich_method_ELISA > IBL/Inselzell Ak ELISA/NM59081/
商品详细IBL/Inselzell Ak ELISA/NM59081/
IBL/Inselzell Ak ELISA/NM59081/
IBL/Inselzell Ak ELISA/NM59081/
商品编号: NM59081
品牌: TECAN
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 夹心法ELISA
公司分类: Sandwich_method_ELISA
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
Kitsize12x8
MethodELISA
Incubationtime2x1h,1x30min
Standardrangenegativeandpositivecontrol
Specimen/Volumes25µLserum
Substrate/isotopePNPP405nm
RegulatoryStatus:EU:CE
Detailsfor: Inselzell-AkELISA
Insulin-dependentdiabetesmellitus(IDDM)orTypeIDiabetesisadebilitatingchronicdiseasethatimpairsproductionandsecretionofthekeyhormoneinsulinandaltersbloodsugarmetabolism.InsulinissynthesisedandsecretedbypancreaticisletcellsorisletsofLangarhans.ThedisruptionofinsulinsynthesisiscausedbyimmunologicaldestructionoftheisletcellsbyautoantibodiesinIDDMpatients.Suchabnormalities(autoimmunity)maybegeneticallyinheritedand/ortriggeredbyexposuretotoxicchemicals,viralinfectionsandvariousformsofstress.IDDMhasacharacteristicasymptomaticprediabeticphasethatmaylastuptoseveralyears.Duringthisperiod,theaffectedindividualsexhibitthediminishingearly-phasereleaseofinsulininresponsetoanintravenous/oralglucosechallenge.Inthemajorityofcases,theseindividualscarrycirculatingisletcellautoantibodies(ICA)and/orinsulinautoantibodies(IAA).ICAcanbedetectedasearlyaseightyearspriortotheclinicalonsetofIDDMandthusmayserveasanearlyindicatorofthediseaseorofpredispositiontoit.IndividualswhoareICA-positivemayshowaprogressivelossoftheisletcellfunctionasindicatedbydisruptionoftheearly-phaseinsulinrelease.Whenthisearlyphaseinsulinreleasecompletelystops,clinicallyovertIDDMdevelops.ICAarepresentin70%ofpatientswithrecentonsetofIDDMcomparedwith0.1-0.5%ofthecontrolnon-diabeticpopulation.ICAarealsodetectedinfirstdegreerelativesofIDDMpatients.TheseindividualscomprisethesegmentofhumanpopulationwhoareatahighriskofdevelopingIDDM.SeveralstudiesreportedthattheICA-positivefirstdegreerelativesofIDDMpatientssubsequentlydevelopeddiabetes.OtherstudiesalsosuggestedthatthepresenceofserumICAandIAAisanindicatorortheenhancedlikelihoodtodevelopIDDM.Therefore,SEROlogicaldetectionofICAmaybeapowerfultoolforearlydiagnosisofIDDM.ThesignificanceoftheseautoantibodiesasMarkersofIDDMisalsoillustratedbytheirpresenceinnondiabeticindividualswhoultimatelydevelopIDDM.Riley,et.al.recentlyreportedthatdeterminationofICAinType2DiabetespatientscouldidentifyIDDMpriortotheonsetofclinicalsymptomsandpredicttheneedforinsulintherapy.Thus,thosepatientswhoareinitiallydiagnosedwithType2DiabetesandcarryserumICAmaydeterioratetoinsulindependence.EarlydetectionofcirculatingICAisimportanttoidentifytheindividualsinthegeneralpopulation,thesIBLingsandfamiliesofIDDMpatientswhoareatahigherriskofdevelopingthisdiseasebecauseoftheirgeneticpredispositiontodiabetes.AtarecentinternationalworkshoponICA,theimminentneedforanELISAtestforthedeterminationofisletcellautoimmunitywasemphasized.Currently,serumICAaredeterminedbyindirectimmunofluorescenceandhistochemicalmethodsemployingfrozenunfixedhuman/primateorratpancreaticsectionsassubstrates.Despitevariousattemptstoimproveandmodifythisproceduresinceitsoriginaldescriptionin1974,theindirectimmunoflourescence/histochemicaltechniquesuffersfrominherentmethodologicalproblems.Standardisationofthetechniquehasproventobeverydifficult.ThereliABIlityofthis"frozen-section"techniqueislimitedbyfactorssuchasthevariationfromonepancreastoanother,theinevitableneedforunfixedpancreatictissueandinfrequentavailabilityofthesuitabletissue.ThisICAtestisaqualitativeELISAtestforinvitrodetectionofcirculatingIgGantibodiesagainstpancreaticisletcellantigens.
ForconcretedatapleaseconsulttheInstructionforUseinthedownloadboxontherightside.
品牌介绍
IBL我们的愿景是通过Tecan技术,产品和支持,为世界各地的每个实验室提供支持。我们旨在通过无与伦比的专业知识,产品和客户支持来塑造生命科学和临床诊断自动化工作流程的未来。